Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?

Om Prakash Choudhary; Priyanka; Jivan Q. Ahmed; Teroj A. Mohammed; Indraj Singh; Alfonso J. Rodriguez-Morales

doi:10.1080/21645515.2021.2007015

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?

Om Prakash Choudhary, Priyanka, Jivan Q. Ahmed, Teroj A. Mohammed, Indraj Singh, Alfonso J. Rodriguez-Morales

Maestría en epidemiología clínica y bioestadística

Research output: Contribution to journal › Comment/debate

9 Scopus citations

Abstract

Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19.

Original language	English
Pages (from-to)	5135-5138
Number of pages	4
Journal	Human Vaccines and Immunotherapeutics
Volume	17
Issue number	12
DOIs	https://doi.org/10.1080/21645515.2021.2007015
State	Published - 2021

Keywords

COVID-19
SARS-CoV-2
cocktail
efficacy
immunogenicity
recommendations
vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/21645515.2021.2007015

Cite this

@article{ce9f9789a9304c0bb3b9e13d113897ab,

title = "Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?",

abstract = "Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19.",

keywords = "COVID-19, SARS-CoV-2, cocktail, efficacy, immunogenicity, recommendations, vaccine",

author = "Choudhary, {Om Prakash} and Priyanka and Ahmed, {Jivan Q.} and Mohammed, {Teroj A.} and Indraj Singh and Rodriguez-Morales, {Alfonso J.}",

note = "Publisher Copyright: {\textcopyright} 2021 Taylor & Francis Group, LLC.",

year = "2021",

doi = "10.1080/21645515.2021.2007015",

language = "Ingl{\'e}s",

volume = "17",

pages = "5135--5138",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Landes Bioscience",

number = "12",

}

TY - JOUR

T1 - Heterologous prime-boost vaccination against COVID-19

T2 - is it safe and reliable?

AU - Choudhary, Om Prakash

AU - Priyanka,

AU - Ahmed, Jivan Q.

AU - Mohammed, Teroj A.

AU - Singh, Indraj

AU - Rodriguez-Morales, Alfonso J.

PY - 2021

Y1 - 2021

N2 - Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19.

AB - Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19.

KW - COVID-19

KW - SARS-CoV-2

KW - cocktail

KW - efficacy

KW - immunogenicity

KW - recommendations

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85121442707&partnerID=8YFLogxK

U2 - 10.1080/21645515.2021.2007015

DO - 10.1080/21645515.2021.2007015

M3 - Comentario/Debate

C2 - 34898381

AN - SCOPUS:85121442707

SN - 2164-5515

VL - 17

SP - 5135

EP - 5138

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 12

ER -

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this